Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.006 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |